HOME › DRUGS › EVOLOCUMAB
ACTIVE SUBSTANCE / INN

EVOLOCUMAB

Brand name(s): Repatha, REPATHA
FDA LISTED
EMA LISTED
PRESCRIPTION
AUTHORISED
BLA125522
Dyslipidemias;Hypercholesterolemia
ACTIVE SUBSTANCE
Evolocumab
REGULATORS
FDA · EMA
SPONSORS / MAH
Amgen Europe B.V., AMGEN INC
TOTAL APPLICATIONS
2
FDA APPLICATIONS (DRUGS@FDA)
BRAND NAMEAPPLICATIONSPONSORSTATUS
REPATHABLA125522AMGEN INCPrescription
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
RepathaAmgen Europe B.V.Authorised17/07/2015Dyslipidemias;Hypercholesterolemia

FULL INTELLIGENCE ON EVOLOCUMAB

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →